A detailed history of Farther Finance Advisors, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 454 shares of RDY stock, worth $7,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
454
Previous 317 43.22%
Holding current value
$7,200
Previous $23.9 Million 50.89%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$75.41 - $84.21 $10,331 - $11,536
137 Added 43.22%
454 $36.1 Million
Q2 2024

Jul 31, 2024

BUY
$68.26 - $76.19 $3,754 - $4,190
55 Added 20.99%
317 $23.9 Million
Q1 2024

May 13, 2024

SELL
$67.36 - $77.59 $25,596 - $29,484
-380 Reduced 59.19%
262 $19.4 Million
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $39,011 - $42,429
607 Added 1734.29%
642 $44.7 Million
Q3 2023

Nov 13, 2023

BUY
$61.9 - $72.77 $2,166 - $2,546
35 New
35 $2.34 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.63B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.